+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recombinant human granulocyte colony-stimulating factor therapy for sepsis in infants with neutropenia



Recombinant human granulocyte colony-stimulating factor therapy for sepsis in infants with neutropenia



Pediatrics 103(6 Pt 1): 1310-1311




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047189914

Download citation: RISBibTeXText

PMID: 10400521


Related references

A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Archives of Disease in Childhood. Fetal and Neonatal Edition 84(3): F172-F176, 2001

Reversal of sepsis-associated neonatal neutropenia with recombinant human granulocyte colony stimulating factor. Pediatric Research 39(4 Part 2): 223A, 1996

Neonatal sepsis associated with neutropenia The in vivo effect of recombinant human granulocyte colony-stimulating-factor. Experimental Hematology 23(8): 880, 1995

Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia. Mymensingh Medical Journal 21(3): 469-474, 2012

Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia. Journal of the Formosan Medical Association 114(2): 174-179, 2015

Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Pediatric Infectious Disease Journal 21(11): 1061-1065, 2002

Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial. Journal of Tropical Pediatrics 58(1): 12-18, 2012

Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony stimulating factor. Annals of Internal Medicine 109(10): 789-795, 1988

Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency. Acta Paediatrica Japonica 35(2): 124-126, 1993

Double-blind, randomized comparison of the safety profile of granulocyte macrophage colony stimulating factor vs recombinant granulocyte colony stimulating factor in advanced HIV infected patients with neutropenia. Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 33: 246, 1993

Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia. Journal of Pediatrics 129(4): 551-558, 1996

Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia. Blood 72(6): 2045-2047, 1988

Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia. BioTherapy 3(4): 297-307, 1991

A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants. Pediatrics and Neonatology 56(3): 171-175, 2015

The effect of recombinant human granulocyte macrophage colony stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Annals of Internal Medicine 111(11): 887-892, 1989